✦ LIBER ✦

ASPECCT: panitumumab versus cetuximab for colorectal cancer

✍ Scribed by Sunakawa, Yu; Ichikawa, Wataru; Sasaki, Yasutsuna

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ASPECCT: panitumumab versus cetuximab fo

✍ Hawkes, Eliza A; Wong, Rachel 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 50 KB

ASPECCT: panitumumab versus cetuximab fo

✍ Price, Timothy J; Peeters, Marc; Ruff, Paul; Murugappan, Swaminathan; Sidhu, Rog 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 39 KB

Panitumumab versus cetuximab in patients

✍ Price, Timothy J; Peeters, Marc; Kim, Tae Won; Li, Jin; Cascinu, Stefano; Ruff, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 592 KB

Molecular Mechanisms of Resistance to Ce

✍ Bardelli, A.; Siena, S. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 367 KB

Cetuximab and panitumumab in KRAS wild-t

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Mara Ghilardi; Sandro Barni 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 461 KB

Anti-EGFR Monoclonal Antibodies for Trea

✍ You, Benoit; Chen, Eric X. 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 404 KB